We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

72 hedge funds and large institutions have $84.6M invested in Orchard Therapeutics plc American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 26 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 79 → 72 (-7)

25% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 24

46% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 26

49% less capital invested

Capital invested by funds: $167M → $84.6M (-$82.8M)

53% less call options, than puts

Call options by funds: $82K | Put options by funds: $175K

Holders
72
Holders Change
-7
Holders Change %
-8.86%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
14
Reduced
26
Closed
24
Calls
$82K
Puts
$175K
Net Calls
-$93K
Net Calls Change
+$1M

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$3.92M
2
CA
CHI Advisors
New York
+$3.92M
3
SG Americas Securities
SG Americas Securities
New York
+$1.07M
4
Two Sigma Investments
Two Sigma Investments
New York
+$897K
5
AFM
Anson Funds Management
Texas
+$576K

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$8.82M
2
CC
Casdin Capital
New York
-$5.92M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.06M
4
VC
Vivo Capital
California
-$3.05M
5
JP Morgan Chase
JP Morgan Chase
New York
-$2.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
Artisan Partners
1
Artisan Partners
Wisconsin
$13M -$1.7M -103,031 -9%
RCM
2
RA Capital Management
Massachusetts
$12.8M -$2.21M -133,393 -12%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$11.4M – – –
Federated Hermes
4
Federated Hermes
Pennsylvania
$11M +$3.92M +237,295 +40%
DM
5
Deerfield Management
New York
$9.17M – – –
CA
6
CHI Advisors
New York
$8.51M +$3.92M +236,789 +58%
JP Morgan Chase
7
JP Morgan Chase
New York
$2.43M -$2.27M -137,404 -43%
AG
8
Artal Group
Luxembourg
$2.38M – – –
PIM
9
Platinum Investment Management
Australia
$1.76M +$425K +25,685 +24%
Temasek Holdings
10
Temasek Holdings
Singapore
$1.32M – – –
Renaissance Technologies
11
Renaissance Technologies
New York
$1.29M -$146K -8,837 -8%
New York State Common Retirement Fund
12
New York State Common Retirement Fund
New York
$1.26M -$576K -34,839 -27%
SG Americas Securities
13
SG Americas Securities
New York
$858K +$1.07M +64,967 New
BlackRock
14
BlackRock
New York
$826K -$45.2K -2,732 -4%
Two Sigma Investments
15
Two Sigma Investments
New York
$716K +$897K +54,221 New
EP
16
Eversept Partners
New York
$554K -$248K -15,000 -26%
Morgan Stanley
17
Morgan Stanley
New York
$522K +$407K +24,609 +165%
WP
18
Woodline Partners
California
$477K – – –
AFM
19
Anson Funds Management
Texas
$460K +$576K +34,827 New
GCP
20
GSA Capital Partners
United Kingdom
$447K -$59.6K -3,605 -10%
HCA
21
Harbor Capital Advisors
Illinois
$364K +$456K +27,587 New
CAM
22
Cormorant Asset Management
Massachusetts
$339K – – –
Citadel Advisors
23
Citadel Advisors
Florida
$250K -$9.64K -583 -3%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$250K +$314K +18,970 New
SEI Investments
25
SEI Investments
Pennsylvania
$239K +$46.1K +2,786 +18%
1
2 3 4

ORTX Hedge Fund Activity: Q4 2021 in Review

72 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q4 2021, worth a combined $84.6M — down 49% from $167M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of ORTX and 18 opened new positions — a net loss of 6 holders — while 26 trimmed existing stakes and 14 added.

The largest buyer was Federated Hermes, adding an estimated $3.92M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $8.82M sold.

  • 72 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q4 2021, down from 79 in Q3 2021.
  • Funds reported $84.6M of Orchard Therapeutics plc American Depositary Shares stock for Q4 2021, down 49% quarter-over-quarter.
  • 18 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q4 2021 and 24 closed out, a net change of -6 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q4 2021 was Federated Hermes, an estimated $3.92M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q4 2021 was Avidity Partners Management, an estimated $8.82M sold.

Based on aggregated 13F filings for Q4 2021.